Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oncorine plus mFOLFOX6 and bevacizumab for unresectable colorectal adenocarcinoma with liver metastases
ChiCTR1900027922Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Oct 2019
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Oncorine in colorectal adenocarcinoma and colorectal cancer (CRC) (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: objective response rate. Started Oct 2019; status: recruiting.
02
Drugs
Oncorine
03
Conditions
colorectal adenocarcinomacolorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR1900027922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027922.